Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Elma › NPI 1740211028
Hospital

Grays Harbor County Public Hospital District No 1

Grays Harbor County Public Hospital District No 1 was paid $50.05M by Medicaid between Jan 2018 and Dec 2024, across 244 billing codes. Its largest line is 99283, emergency room visit (moderate) — 17% of everything it billed.

33Billing provider infoGRAYS HARBOR COUNTY PUBLIC HOSPITAL DISTRICT NO 1
ELMA, WA 98541
33aNPI1740211028assigned 07/05/2006
33bProvider typeCritical Access Hospital
28Total paid$50.05M
24GClaims603,173
24DCodes billed244
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Washington

Rank by total paid#1 of 30
Median peer was paid$9.10M
This provider vs. median5.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201876,970$4.69M
201985,205$5.23M
202082,131$5.25M
202192,311$8.08M
2022101,221$10.96M
202386,169$7.97M
2024incomplete79,166$7.88M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 17% 59,579 53,769 $8.63M
74177 Computed tomography, abdomen and pelvis; with contrast material 12% 4,075 3,868 $5.95M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 10% 20,808 18,476 $5.18M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.3% 6,850 5,801 $3.66M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.4% 22,156 20,455 $2.22M
74176 Computed tomography, abdomen and pelvis; without contrast material 3.8% 1,877 1,764 $1.90M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.7% 7,819 6,968 $1.38M
70450 Computed tomography, head or brain; without contrast material 2.5% 2,581 2,407 $1.23M
71046 Radiologic examination, chest; 2 views 2.2% 7,864 7,482 $1.11M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 4,890 3,837 $967K
80305 1.7% 14,427 11,266 $875K
80053 Comprehensive metabolic panel 1.6% 37,508 33,777 $804K
232 more codes
96375 Therapeutic injection; each additional sequential IV push 1.5% 6,486 $748K
84443 Thyroid stimulating hormone (TSH) 1.2% 13,396 $598K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.2% 33,764 $595K
71045 Radiologic examination, chest; single view 1.0% 6,008 $524K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.0% 11,059 $518K
96361 Intravenous infusion, hydration; each additional hour <1% 4,735 $476K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,850 $454K
71275 Computed tomographic angiography, chest, with contrast material <1% 265 $364K
80061 Lipid panel <1% 9,595 $358K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,404 $357K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 6,576 $355K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 539 $347K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,522 $306K
36415 Collection of venous blood by venipuncture <1% 37,494 $304K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 8,713 $291K
73630 <1% 2,383 $287K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 584 $281K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 3,202 $278K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,931 $276K
73610 <1% 1,993 $259K
73560 <1% 2,210 $257K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 240 $253K
72125 Computed tomography, cervical spine; without contrast material <1% 274 $242K
73130 <1% 1,870 $237K
72100 <1% 1,648 $233K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 922 $226K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,647 $218K
83036 Hemoglobin; glycosylated (A1C) <1% 8,602 $216K
87086 Culture, bacterial; quantitative colony count, urine <1% 8,986 $202K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,789 $197K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,121 $196K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 243 $191K
73030 <1% 1,642 $189K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 6,495 $183K
73110 <1% 1,257 $181K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 3,682 $165K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 3,673 $165K
87428 <1% 4,246 $164K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,143 $158K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,536 $152K
83880 <1% 2,798 $137K
84484 <1% 7,357 $135K
76830 Ultrasound, transvaginal <1% 481 $135K
81025 <1% 10,217 $119K
G0378 Hospital observation service, per hour <1% 116 $116K
83690 <1% 7,394 $116K
83721 <1% 6,848 $113K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 3,417 $112K
96376 <1% 1,653 $107K
81001 <1% 13,230 $102K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,288 $101K
76536 <1% 313 $87K
84439 <1% 3,621 $85K
85610 <1% 6,087 $84K
87186 <1% 3,256 $80K
71250 <1% 109 $79K
73502 <1% 481 $77K
10060 <1% 234 $72K
81003 <1% 9,320 $67K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 66 $66K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 209 $63K
83605 <1% 2,954 $62K
74018 <1% 511 $61K
84702 <1% 1,494 $59K
82728 <1% 1,764 $58K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 405 $57K
80048 Basic metabolic panel (calcium, ionized) <1% 3,676 $57K
72040 <1% 412 $57K
87807 <1% 1,904 $56K
87077 <1% 2,169 $51K
85027 <1% 3,696 $51K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 683 $49K
82043 <1% 2,460 $45K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,378 $45K
86780 <1% 1,979 $45K
84153 <1% 795 $44K
86803 <1% 3,252 $44K
87040 <1% 1,403 $44K
97161 <1% 699 $42K
76801 <1% 150 $41K
97162 <1% 652 $38K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 635 $37K
85379 <1% 1,680 $36K
82570 <1% 2,447 $35K
96367 <1% 259 $31K
84403 <1% 605 $31K
87070 <1% 1,155 $30K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,175 $30K
83735 <1% 1,914 $30K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 2,108 $29K
85007 <1% 3,274 $29K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,639 $28K
86140 <1% 2,129 $28K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 839 $26K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,596 $25K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,180 $23K
85652 <1% 2,166 $22K
86703 <1% 1,788 $21K
73140 <1% 152 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,084 $21K
36592 <1% 1,110 $19K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,414 $18K
76642 <1% 84 $17K
82607 <1% 1,771 $17K
82805 <1% 362 $17K
73070 <1% 159 $16K
87340 <1% 1,237 $16K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 73 $16K
83550 <1% 2,014 $16K
84703 <1% 755 $14K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,255 $14K
90715 <1% 344 $12K
86364 <1% 302 $12K
84481 <1% 1,268 $11K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 3,865 $11K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 522 $11K
86704 <1% 991 $11K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 190 $11K
73090 <1% 101 $10K
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,631 $10K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 339 $10K
87210 <1% 792 $9K
87522 Neg quan hep c or qual rna <1% 102 $9K
82784 <1% 390 $9K
94760 <1% 737 $9K
86708 <1% 808 $9K
J1170 Injection, hydromorphone, up to 4 mg <1% 1,417 $8K
86258 <1% 130 $8K
83516 <1% 113 $7K
97803 <1% 159 $7K
J7050 Infusion, normal saline solution, 250 cc <1% 1,243 $7K
86706 <1% 646 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 407 $7K
73590 <1% 55 $6K
86231 <1% 217 $6K
72072 <1% 39 $6K
93971 <1% 26 $6K
86709 <1% 242 $6K
82150 <1% 277 $5K
86592 <1% 29 $5K
84402 <1% 240 $5K
83655 <1% 371 $5K
93970 <1% 12 $5K
J2704 Injection, propofol, 10 mg <1% 432 $5K
86038 <1% 392 $5K
82962 <1% 499 $4K
83540 <1% 617 $4K
12001 <1% 16 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 628 $4K
74019 <1% 28 $3K
71101 <1% 26 $3K
86431 <1% 252 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 267 $3K
97802 <1% 43 $3K
85018 <1% 355 $3K
J2060 Injection, lorazepam, 2 mg <1% 768 $3K
86255 <1% 72 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 649 $3K
83993 <1% 30 $3K
80320 <1% 696 $3K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 13 $3K
86850 <1% 41 $3K
86900 <1% 94 $2K
85730 <1% 161 $2K
86901 <1% 57 $2K
36416 <1% 301 $2K
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 224 $2K
86308 <1% 129 $2K
99213 Doctor's office visit, returning patient (routine) <1% 26 $2K
00811 <1% 16 $2K
86804 <1% 26 $2K
80329 <1% 218 $2K
00813 <1% 14 $2K
J3370 Injection, vancomycin hcl, 500 mg <1% 38 $2K
80050 General health panel <1% 14 $2K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 41 $2K
82746 <1% 154 $2K
83525 <1% 134 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 149 $1K
84154 <1% 109 $1K
86003 <1% 12 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 181 $1K
51702 <1% 13 $1K
86235 <1% 93 $1K
96368 <1% 16 $1K
84100 <1% 93 $1K
84030 <1% 87 $977.57
86225 <1% 81 $949.36
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 164 $941.04
87177 <1% 13 $806.73
82247 <1% 33 $767.91
97535 Self-care/home management training, each 15 minutes <1% 19 $758.07
82653 <1% 14 $750.20
99232 Hospital visit by a doctor, follow-up day <1% 31 $711.24
87075 <1% 29 $691.68
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 158 $685.93
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 57 $636.16
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 13 $563.77
90756 <1% 30 $541.75
J3480 Injection, potassium chloride, per 2 meq <1% 20 $504.28
87081 <1% 13 $498.64
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 856 $444.04
90686 <1% 23 $442.20
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 50 $430.10
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 62 $419.18
80076 <1% 32 $412.65
85008 <1% 305 $410.45
86317 <1% 51 $370.31
J1790 Injection, droperidol, up to 5 mg <1% 30 $356.38
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 182 $341.59
J2550 Injection, promethazine hcl, up to 50 mg <1% 56 $303.96
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 25 $297.75
80179 <1% 14 $292.30
80143 <1% 14 $292.30
J3490 Unclassified drugs <1% 39 $262.85
82248 <1% 20 $232.00
86695 <1% 15 $230.52
82550 <1% 15 $217.79
87209 <1% 13 $204.29
86141 <1% 14 $144.55
80321 <1% 26 $134.16
86762 <1% 12 $113.40
J1940 Injection, furosemide, up to 20 mg <1% 33 $90.20
84480 <1% 12 $84.62
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 22 $73.72
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 151 $66.82
J7510 Prednisolone oral, per 5 mg <1% 15 $63.97
J1815 Injection, insulin, per 5 units <1% 15 $34.77
J1171 Injection, hydromorphone, 0.1 mg <1% 16 $26.79
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 51 $3.71
A9270 Non-covered item or service <1% 893 $2.53
T1015 A visit at a community health center or clinic (one all-in rate) 0% 58 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMARTIN, JOSHUA (CEO)